A number of different strategies can be developed to protect people against atherosclerosis or to treat patients with clinical symptoms thereof. In our opinion, DNA and protein vaccination in ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

Two conditions within this category are atherosclerosis and arteriosclerosis, which are often confused. Both conditions involve changes in the arterial walls. However, arteriosclerosis is the ...

In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain.

The following is a summary of “Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis,” published in ...

Atherosclerosis is a chronic, systemic, inflammatory and metabolic disease and pathologic process characterized by the accumulation of cholesterol and calcium plaque within the arterial wall.

The following is a summary of “Relationship between left ventricular shape and cardiovascular risk factors: comparison ...

The factors underlying accelerated atherosclerosis in diabetes extend beyond dyslipidemia, hypertension and obesity. Even after correction of these typical risk factors, patients with diabetes ...